![Paul A. Hyslop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul A. Hyslop served as a Board Member and Director of Research & Development at EndGenitor Technologies, Inc. He also worked as a Principal at Eli Lilly & Co. Prior to his professional experience, he earned an undergraduate and doctorate degree from The University of Southampton.
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
EndGenitor Technologies, Inc.
 EndGenitor Technologies, Inc. BiotechnologyHealth Technology Commercialized adult stem cell products | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
EndGenitor Technologies, Inc.
EndGenitor Technologies, Inc. BiotechnologyHealth Technology Commercialized adult stem cell products | Health Technology |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
